NDC 0409-7809-31 - Dopamine Hydrochloride in Dextrose
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0409-7809
- Requested NDC
- 0409-7809-31
- Package NDCs from labels
- 0409-7809-11, 0409-7809-22, 0409-7809-31, 0409-7809-24
- Manufacturer
- Hospira, Inc.
- Effective date
- 2026-05-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Dopamine Hydrochloride in Dextrose - Hospira, Inc. | Hospira, Inc. | 2026-05-12 | HUMAN PRESCRIPTION DRUG LABEL |
| DOPAMINE HYDROCHLORIDE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-01-29 | HUMAN PRESCRIPTION DRUG LABEL |
| DOPAMINE HCI IN 5% DEXTROSE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-01-27 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0409-7809-11 | Dopamine Hydrochloride in Dextrose | 250 mL in 1 BAG | INJECTION, SOLUTION | 250 | 27 | |
| 0409-7809-22 | Dopamine Hydrochloride in Dextrose | 12 in 1 CARTON | INJECTION, SOLUTION | 12 | 27 | |
| 0409-7809-24 | Dopamine Hydrochloride in Dextrose | 12 in 1 CARTON | INJECTION, SOLUTION | 12 | 27 | |
| 0409-7809-31 | Dopamine Hydrochloride in Dextrose | 500 mL in 1 BAG | INJECTION, SOLUTION | 500 | 27 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0409-7809-11 | ML - Milliliter | 0409-7809 | 0f5f70dd-c881-4534-ba67-7b1e9245d94c | 1 | 2019-08-06 |
| 0409-7809-22 | ML - Milliliter | 0409-7809 | 33d938a5-3c98-4dcc-9057-f90b1eaefc6d | 1 | 2013-02-13 |
| 0409-7809-24 | ML - Milliliter | 0409-7809 | 2c6e271f-0637-4254-bef2-50809e099c09 | 1 | 2013-02-13 |
| 0409-7809-31 | ML - Milliliter | 0409-7809 | 224c8f8e-53f6-489b-8d4c-e7b669bc7978 | 1 | 2019-08-06 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Fendall 1000 Pure Flow | PURIFIED WATER | Protective Industrial Products, Inc. | 55a2f4da-bb1e-8ead-e063-6394a90af72e | 2026-07-02 | Warnings | 059QF0KO0R |
| Sterile Eyesaline Eyewash | STERILE EYESALINE EYEWASH | Protective Industrial Products, Inc. | 55a290e8-8310-8be4-e063-6394a90abdce | 2026-07-02 | Warnings | 059QF0KO0R |
| Eyesaline Emergency Eyewash | PURIFIED WATER | Protective Industrial Products, Inc. | 55a261c2-725d-6765-e063-6294a90a3260 | 2026-07-02 | Warnings | 059QF0KO0R |
| Remodulin | TREPROSTINIL | United Therapeutics Corporation | 6c80bb38-e8db-4138-9f0d-dbbf9c673185 | 2026-07-02 | Warnings, Adverse reactions | 059QF0KO0R |
| SET 4TE HOMO | ADEPS SUILLUS, BRYONIA (ALBA), CALCAREA PHOSPHORICA, CHOLINUM, DNA, DOPAMINE (HYDROCHLORIDE), FERRUM PHOSPHORICUM, FOLIC ACID, INSULINUM (HUMAN), LEPTIN, MAGNESIA MURIATICA, L-METHIONINE, METHYLCOBALAMIN, PROTEUS (VULGARIS), RHUS TOX, RIBOFLAVINUM, RUTA GRAVEOLENS, SACCHARUM OFFICINALE, THIOSINAMINUM, ZINCUM METALLICUM | Deseret Biologicals, Inc. | e7b8d75b-f2bc-4013-91e7-bf5bbec11a90 | 2026-06-25 | Warnings | 7L3E358N9L |
| Leukotrap WB System | CPDA-1 BLOOD BAG COLLECTION SYSTEM | GVS TM INC | 54fd8a72-0527-df0c-e063-6294a90abe75 | 2026-06-24 | LX22YL083G | |
| Leukotrap WB System | CPDA-1 BLOOD BAG COLLECTION SYSTEM | GVS TM INC | 54fddca1-b40c-7af0-e063-6294a90a410e | 2026-06-24 | LX22YL083G | |
| Leukotrap WB System | CPDA-1 BLOOD BAG COLLECTION SYSTEM | GVS TM INC | 54fdf83e-f641-1f69-e063-6394a90ab750 | 2026-06-24 | LX22YL083G | |
| Fendall 2000 Pure Flow | PURIFIED WATER | Honeywell Safety Products USA, Inc. | 37dead3e-60cb-88ae-e063-6294a90a8f70 | 2026-06-24 | Warnings | 059QF0KO0R |
| Dextrose | DEXTROSE MONOHYDRATE | Hospira, Inc. | 672264e3-9709-4bba-2a9d-12bf70c7396a | 2026-06-24 | Warnings, Adverse reactions | LX22YL083G |
| Bacteriostatic Water | BACTERIOSTATIC WATER | Fujian Genohope Biotech Ltd. | 54f66b82-c9e5-a2bc-e063-6394a90adbbc | 2026-06-23 | 059QF0KO0R | |
| Humalog | INSULIN LISPRO | Eli Lilly and Company | c8ecbd7a-0e22-4fc7-a503-faa58c1b6f3f | 2026-06-16 | Warnings, Adverse reactions | 059QF0KO0R |
| ACD A | CITRIC ACID MONOHYDRATE, DEXTROSE MONOHYDRATE, AND TRISODIUM CITRATE DIHYDRATE | Terumo BCT, Ltd. | 395aec48-198a-4aed-8e38-7accfb3232f9 | 2026-06-15 | Warnings, Adverse reactions | LX22YL083G |
| BM BM182 DROPS | HEPAR SULF, GRAPHITES, MERC SOL, MURIATIC ACID | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 5423bde6-3e31-38b0-e063-6294a90afb2d | 2026-06-13 | Warnings | QTT17582CB |
| BM BM182 DROPS | HEPAR SULF, GRAPHITES, MERC SOL, MURIATIC ACID | BM Private Limited | 540d11e3-e4a1-0ca2-e063-6394a90a3c26 | 2026-06-12 | Warnings | QTT17582CB |
| BM BM70 DROPS | ANTIM CURD, FERR MET, PHOSPHORUS, SULPHUR, WIESBADEN, THUJA, VERATRUM ALB | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 54113d1f-e8e7-6b4c-e063-6394a90a0edf | 2026-06-12 | Warnings | 059QF0KO0R |
| BM BM70 DROPS | ANTIM CURD, FERR MET, PHOSPHORUS, SULPHUR, WIESBADEN, THUJA, VERATRUM ALB | BM Private Limited | 53fa21d9-1f80-2e69-e063-6394a90ab9f3 | 2026-06-11 | Warnings | 059QF0KO0R |
| DEXTROSE | DEXTROSE MONOHYDRATE | Baxter Healthcare Corporation | 3bb406a9-f5cb-403a-b1bb-5c4facbea3d5 | 2026-06-11 | Warnings, Adverse reactions | LX22YL083G |
| XIMONTH Fungi Free Bee Venom Nail Soothing Serum | GLYCERIN | Shantou Ximonth Biotechnology Co., Ltd. | 53bab969-8407-6334-e063-6294a90aa5d1 | 2026-06-08 | Warnings | 059QF0KO0R |
| Dextrose | DEXTROSE MONOHYDRATE | Hospira, Inc. | 10e98cb0-31a5-4ad1-3eaa-aa4af387a42d | 2026-06-02 | Warnings, Adverse reactions | LX22YL083G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.